Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma

Clinical trial NCT06675201 · RECRUITING

Trial details

NCT number: NCT06675201
Sponsor: Sichuan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma (ESCC)Neoantigen-loaded Dendritic Cell Vaccine Immune Checkpoint Inhibitors (ICIs)

Start date: 2024-10-01
Primary completion: 2027-10-01
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.